PANACEABIO
Panacea Biotec Limited
Pharmaceuticals
Share price
₹411
Market cap
₹2,514 Cr
1Y return
▲ 2%
A research-based biotechnology company, Panacea Biotec develops and manufactures pharmaceutical products and vaccines across multiple therapeutic areas including immunology, oncology, and infectious diseases. Incorporated in 1984, the company operates through integrated manufacturing facilities and maintains a strong focus on developing affordable healthcare solutions for emerging markets. Its distinctive strength lies in combining advanced biotechnology research capabilities with specialized vaccine production expertise and a commitment to accessible medicine.
Investors holding Panacea Biotec Limited
Latest move
Massachusetts Institute Of TechnologyIncreased
Massachusetts Institute Of Technology increased its stake in Panacea Biotec from 1.12% to 1.71%, raising its shareholding from 6,85,000 to 10,50,000 shares. The value of the additional 3,65,000 shares is ₹16.86 Cr at ₹461.95 apiece.
Sign in to read more
Track the whales in Panacea Biotec Limited
Get alerted the moment a top investor buys or sells.
Get started